Bret Jensen

Private credit markets continue to deteriorate with default rates rising. Click to read what investors should know about this challenging situation.

Rising interest rates hit housing, big-ticket goods & commercial real estate. Click to read this detailed investing strategy.

Aquestive Therapeutics is highlighted for its growth potential driven by an upcoming NDA resubmission for Anaphylm, an orally delivered epinephrine product. Learn more about AQST stock here.

CG Oncology (CGON) advances cret for NMIBC with strong CR rates and best-in-class safety; see trial results and 2026–2027 catalysts. See more here.

Equity markets continue to surge on AI optimism; credit markets signal rising stress and potential systemic risks reminiscent of 2007. Read full analysis here.

Prime Medicine possesses promising gene editing technology but faces significant dilution risk and cash constraints. Read more on PRME stock here.

Three large and well-known names that will be among the first casualties when the AI Bubble finally pops. Read the full analysis here.

The month of July saw the NASDAQ fall just over 3% as semiconductors had their worst month since 2008. Check out the predictions for the month of August.

MeiraGTx gene therapy upside: AAV2-hAQP1 for radiation xerostomia targets $3.7B market; Phase 2 data 2Q27. Click for more on MGTX stock.

Is the AI-driven equity rally starting to falter? Read why hyperscaler stocks are in the red.